Skip to content

The effect of progestrone on preterm labour in patient who are pregnant with ART teqnique

Evaluation the Effect of 17 alpha-hydroxyprogestrone caproate on dcreasing preterm labour and second trimester miscarriage in women pregnant with ART

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012101611132N1
Enrollment
106
Registered
2012-12-24
Start date
2010-10-23
Completion date
Unknown
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

preterm labour. complication of labour and delivery

Interventions

Intervention 1: control group:drug with all chachtristic of of 17alpha- hydroxyprogestrone caproate:only without efficient material of this drug:intramusculary injected from16-36weeks of gestation.

Sponsors

Aburaihan Pharmacy company
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Pregnancy using ART Gestational age of 16 weeks Using progesterone for luteal phase support

Exclusion criteria

Exclusion criteria: Twin or multiple pregnancies History of preterm labor History of previous abortion History of chronic diseases such as Diabetes mellitus, Hypertention, and Hypo or Hyperthyroidism Uterine anatomical problems

Design outcomes

Primary

MeasureTime frame
Labour under37week/34-37week-32-34week and second trimestre abortion. Timepoint: weekly from16-36weeks of gestation. Method of measurement: Quastisonaries.;Etiology of preterm labour. Timepoint: Weekly from16-36weeks of gestations. Method of measurement: Quastionaries.

Secondary

MeasureTime frame
NICU admission. Timepoint: After live birth. Method of measurement: Quastionaries.;Neonatal birth weigh. Timepoint: After live birth. Method of measurement: Quastionaries.;Drug complication. Timepoint: Weekly from16-36 weeks of gestation. Method of measurement: Quastionaries.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Hoora Amuzegar

Reseach and Clinical Centre for Infertility of Yazd

amuzegarhoora@yahoo.com+98 35182470856

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 10, 2026